Jelmyto (mitomycin)

Urethral Kit

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Mitomycin is used to treat cancer in the lining of the urinary tract and kidneys. It works by slowing or stopping the growth of cancer cells.

Generic name: mitomycin
Pronunciation: (MYE-toe-MYE-sin)
Therapeutic class: Antineoplastics

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Jelmyto

Intelligence content is not available yet.

Indications

The following indications are listed for Jelmyto:

  • Low-Grade Upper Tract Urothelial Cancer

Also known as: Low-Grade Tcc Of The Upper Urinary Tract, Low-Grade Transitional Cell Carcinoma Of The Upper Tract, Low-Grade Upper Tract Urothelial Carcinoma.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Low-grade upper tract urothelial cancer
C65ICD10CMMalignant neoplasm of renal pelvis
C65.1ICD10CMMalignant neoplasm of right renal pelvis
C65.2ICD10CMMalignant neoplasm of left renal pelvis
C65.9ICD10CMMalignant neoplasm of unspecified renal pelvis
C66ICD10CMMalignant neoplasm of ureter
C66.1ICD10CMMalignant neoplasm of right ureter
C66.2ICD10CMMalignant neoplasm of left ureter
C66.9ICD10CMMalignant neoplasm of unspecified ureter

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data